Evidence map›Paper›PMID 37749550›Full record

ArticleJournal of inflammation (London, England)2023

Genome-wide identification and functional analysis of dysregulated alternative splicing profiles in sepsis.

Dilixiati Tuerdimaimaiti, Buzukela Abuduaini, Shaotao Kang, Jinliang Jiao, Mengchen Li, Wolazihan Madeniyati, Baihetinisha Tuerdi, Gulisitan Aili, Reyila Tuerhong, Ajiguli Kulaxi

Open access · goldAbstract read
In one paragraph

Article in Journal of inflammation (London, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Dilixiati Tuerdimaimaiti *Department of RICU, The First Affiliated Hospital of Xinjiang Medical University, 393 South Li Yu Shan Road, Wulumuqi, Xinjiang, 830054, China.
Buzukela Abuduaini *The Intensive Care Unit, The First Affiliated Hospital of Xinjiang Medical University, Wulumuqi, Xinjiang, 830054, China.
Shaotao KangDepartment of RICU, The First Affiliated Hospital of Xinjiang Medical University, 393 South Li Yu Shan Road, Wulumuqi, Xinjiang, 830054, China.
Jinliang JiaoDepartment of RICU, The First Affiliated Hospital of Xinjiang Medical University, 393 South Li Yu Shan Road, Wulumuqi, Xinjiang, 830054, China.
Mengchen LiDepartment of RICU, The First Affiliated Hospital of Xinjiang Medical University, 393 South Li Yu Shan Road, Wulumuqi, Xinjiang, 830054, China.
Wolazihan MadeniyatiDepartment of RICU, The First Affiliated Hospital of Xinjiang Medical University, 393 South Li Yu Shan Road, Wulumuqi, Xinjiang, 830054, China.
Baihetinisha TuerdiDepartment of RICU, The First Affiliated Hospital of Xinjiang Medical University, 393 South Li Yu Shan Road, Wulumuqi, Xinjiang, 830054, China. 1627971002@qq.com.
Gulisitan AiliDepartment of RICU, The First Affiliated Hospital of Xinjiang Medical University, 393 South Li Yu Shan Road, Wulumuqi, Xinjiang, 830054, China.
Reyila TuerhongDepartment of RICU, The First Affiliated Hospital of Xinjiang Medical University, 393 South Li Yu Shan Road, Wulumuqi, Xinjiang, 830054, China.
Ajiguli KulaxiDepartment of RICU, The First Affiliated Hospital of Xinjiang Medical University, 393 South Li Yu Shan Road, Wulumuqi, Xinjiang, 830054, China.
Xinjiang Medical University · CNFirst Affiliated Hospital of Xinjiang Medical University · CN

Funding

The State Key Laboratory of Causes and Prevention of High Incidence in Central Asia was jointly established by the province and the ministry SKL-HIDCA-2022-7
6 · The paper itself

Abstract

backgroundAn increasing body of evidence now shows that the long-term mortality of patients with sepsis are associated with various sepsis-related immune cell defects. Alternative splicing (AS), as a sepsis-related immune cell defect, is considered as a potential immunomodulatory therapy target to improve patient outcomes. However, our understanding of the role AS plays in sepsis is currently insufficient.

aimThis study investigated possible associations between AS and the gene regulatory networks affecting immune cells. We also investigated apoptosis and AS functionality in sepsis pathophysiology.

methodsIn this study, we assessed publicly available mRNA-seq data that was obtained from the NCBI GEO dataset (GSE154918), which included a healthy group (HLTY), a mild infection group (INF1), asepsis group (Seps), and a septic shock group (Shock). A total of 79 samples (excluding significant outliers) were identified by a poly-A capture method to generate RNA-seq data. The variable splicing events and highly correlated RNA binding protein (RBP) genes in each group were then systematically analyzed.

resultsFor the first time, we used systematic RNA-seq analysis of sepsis-related AS and identified 1505 variable AS events that differed significantly (p <= 0.01) across the four groups. In the sepsis group, the genes related to significant AS events, such as, SHISA5 and IFI27, were mostly enriched in the cell apoptosis pathway. Furthermore, we identified differential splicing patterns within each of the four groups. Significant differences in the expression of RNA Binding Protein(RBP) genes were observed between the control group and the sepsis group. RBP gene expression was highly correlated with variant splicing events in sepsis, as determined by co-expression analysis; The expression of DDX24, CBFA2T2, NOP, ILF3, DNMT1, FTO, PPRC1, NOLC1 RBPs were significant reduced in sepsis compared to the healthy group. Finally, we constructed an RBP-AS functional network.

conclusionAnalysis indicated that the RBP-AS functional network serves as a critical post-transcriptional mechanism that regulates the development of sepsis. AS dysregulation is associated with alterations in the regulatory gene expression network that is involved in sepsis. Therefore, the RBP-AS expression network could be useful in refining biomarker predictions in the development of new therapeutic targets for the pathogenesis of sepsis.

Indexed as

Alternative splicingApoptosisImmune effector cellsRBPSepsis

Identifiers

PMID37749550
PMCPMC10521395
OpenAlexW4387014575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.